A young estate agent, 22-year-old Isabelle Sapherson-Moralee, known as Izzy, tragically died from complications related to a five-year ketamine addiction. After discharging herself from the hospital, she expressed to her mother that she could no longer cope. Izzy’s weight had plummeted to just 5 stone 9 lbs (approximately 35 kg), and she suffered from chronic pain and bladder issues due to her drug use. Despite her mother’s persistent efforts over 18 months to secure help, including warnings to health officials, Izzy’s condition deteriorated rapidly. She died at home just two days after leaving the hospital, with her mother unable to persuade her to seek further medical assistance. The inquest revealed missed opportunities for intervention from health authorities amid rising concerns about ketamine abuse among young people in the UK.
Why It Matters
The case underscores the growing public health crisis surrounding ketamine abuse in the UK, which has seen a staggering 250% increase in usage since 2015. Ketamine, a class B drug, has been linked to numerous student deaths, highlighting the urgent need for effective treatment and intervention strategies. Isabelle’s struggles reflect broader systemic issues within healthcare, particularly for individuals grappling with addiction, and raise critical questions about the adequacy of support services available to vulnerable populations. The tragic outcome of her case serves as a reminder of the importance of addressing mental health and substance abuse issues comprehensively.
Want More Context? 🔎
